# Evaluating PD-1/PD-L1 in Locally Advanced Rectal Cancer by Quantitative Fluorescence Molecular Endoscopy

> **NCT06304597** · PHASE1 · UNKNOWN · sponsor: **University Medical Center Groningen** · enrollment: 18 (estimated)

## Conditions studied

- Locally Advanced Rectal Carcinoma

## Interventions

- **DRUG:** Imfinzi
- **DRUG:** Opdivo

## Key facts

- **NCT ID:** NCT06304597
- **Lead sponsor:** University Medical Center Groningen
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-04-01
- **Primary completion:** 2025-03-01
- **Final completion:** 2025-06-01
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2024-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06304597

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06304597, "Evaluating PD-1/PD-L1 in Locally Advanced Rectal Cancer by Quantitative Fluorescence Molecular Endoscopy". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT06304597. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*